Recent years have seen an increase in the numbers of biotech IPOs and more investment in the sector, however it can still be challenging accessing the finance necessary to fund R&D and to bring products to the market.

As part of the biotech industry you will expect your lawyers to assist you in tackling these difficult financing and market challenges. Our team of sector specialists, including lawyers with technical backgrounds, understands the commercial drivers in this industry and can advise you on the full spectrum of legal matters.

Our clients range from universities and their spin-out companies through to mature biotech multinationals.

For companies looking to fund R&D or ensure the viability of their future pipeline, you will need to undertake the kinds of collaborations that have been behind many of the most successful biotech products. Through our extensive work acting for biotech organisations, we advise on the full range of collaboration and licensing agreements at all stages of product development, including R&D collaborations and commercialisation agreements.

In addition to helping you commercialise your intellectual property, we can help protect it through our knowledge of intellectual property rights enforcement .  

With products at the forefront of biomedical knowledge, the regulatory framework applicable will often be complex. We advise on the regulatory requirements applicable to tissues/cells, biological therapies, in addition to clinical trials. We also advise on pricing, reimbursement and public procurement issues on any authorised product to help ensure its profitability, even in the face of increasing pressure on pricing.

We have extensive experience advising on fundraising for start-ups along with IPOs and capital markets fundraising for developed companies, as well as public and private M&A in the sector.

Read more Read less
High­lights of our ex­per­i­ence in Bi­otech
Roslin Bio­med (the “Dolly the Sheep” com­pany) through its li­fe­cycle and on its ac­quis­i­tion by Ge­r­on Corp.hVIVO plc on PrEP Bio­pharm Lim­ited’s li­cen­cing ar­range­ments to en­able PrEP to de­vel­op and com­mer­cial­ise a pro­phy­lact­ic com­pound on a world­wide ba
Law-Now: Lifes­ci­ences
Vis­it Law-Now for leg­al know-how and com­ment­ary